菌体疗法:将新策略融入到下呼吸道感染治疗中
Atefeh Vaezi1, Thomas Healy1, Golnaz Ebrahimi2
1Division of Pulmonary, Critical Care and Sleep Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, FL, USA.
概括
菌体治疗提供了一种新的方法来对抗由耐药细菌引起的下呼吸道感染 (LRTI). 需要进一步的研究来优化这种有前途的治疗方法用于临床使用.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 下呼吸道感染 (LRTI) 构成了全球重大健康挑战,因抗菌素耐药性 (AMR) 的增加而恶化.
- 耐多药细菌迫切需要开发超越常规抗生素的替代治疗策略.
研究的目的:
- 审查菌体 (菌体) 疗法作为细菌LRTIs的潜在解决方案.
- 综合目前关于菌体疗法的有效性,安全性和临床适用性的证据.
主要方法:
- 对2000-2023年研究的系统性文献综述.
- 包括体外,体内,病例报告和临床试验数据.
- 对菌体与宿主相互作用,药理动力学和药理动力学的分析.
主要成果:
- 菌体疗法显示了特异性,最小的真核毒性和生物膜破坏能力.
- 有证据表明,与抗生素和免疫调节效应有协同作用的潜力.
- 有希望的临床前和早期临床数据存在,但菌体耐药性和成本效益等挑战需要注意.
结论:
- 菌体治疗是一种有希望的,但仍在芽的,对LRTI的治疗,特别是对抗AMR病原体的治疗.
- 进一步的研究对于优化协议,了解脆弱人群中的菌体-宿主动态以及解决监管障碍至关重要.
- 将菌体疗法整合到临床实践中,对于应对AMR危机至关重要.
相关概念视频
Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
Acute Pharyngitis
574
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
574
Pneumonia IV: Management
318
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
318
Chronic Pharyngitis
1.7K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.7K
Lysogenic Cycle of Bacteriophages
62.1K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.1K
Drugs Used in Lower Respiratory Disorders: Overview
402
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
402


